新疗法，新担忧：利妥昔单抗相关的肺损伤。 - Suppr

New therapies, new concerns: rituximab-associated lung injury.

作者信息

Lands Larry C

出版信息

Pediatr Nephrol. 2010 Jun;25(6):1001-3. doi: 10.1007/s00467-010-1476-3. Epub 2010 Mar 2.

DOI:10.1007/s00467-010-1476-3

PMID:20195643

Abstract

摘要

相似文献

New therapies, new concerns: rituximab-associated lung injury.

Pediatr Nephrol. 2010 Jun;25(6):1001-3. doi: 10.1007/s00467-010-1476-3. Epub 2010 Mar 2.

[Cryptococcus neoformans meningoencephalitis in a patient treated with rituximab].

Med Clin (Barc). 2009 Jun 27;133(4):157-8. doi: 10.1016/j.medcli.2008.09.036. Epub 2009 Mar 5.

Organizing pneumonia associated with rituximab: Challenges raised by establishing causality.

Joint Bone Spine. 2008 May;75(3):260-2. doi: 10.1016/j.jbspin.2008.02.001. Epub 2008 Apr 18.

Late-onset neutropenia following rituximab.

Leuk Lymphoma. 2006 Jun;47(6):965-6. doi: 10.1080/10428190600649349.

The infectious consequences of rituximab addition to fludarabine-containing regimens.

Blood. 2006 Apr 1;107(7):3013-4. doi: 10.1182/blood-2005-10-4012.

FDA: Increased HBV reactivation risk with ofatumumab or rituximab.

JAMA. 2013 Oct 23;310(16):1664. doi: 10.1001/jama.2013.281115.

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

Pediatr Pulmonol. 2009 Sep;44(9):922-34. doi: 10.1002/ppul.20864.

Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy.

Ann Oncol. 1999 Oct;10(10):1249-50. doi: 10.1023/a:1008310819049.

Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.

Intern Emerg Med. 2008 Jun;3(2):161-3. doi: 10.1007/s11739-008-0099-1. Epub 2008 Feb 13.

Fatal cytokine release syndrome with chimeric anti-CD20 monoclonal antibody rituximab in a 71-year-old patient with chronic lymphocytic leukemia.

J Clin Oncol. 1999 Jun;17(6):1962-3. doi: 10.1200/jco.1999.17.6.1962.

引用本文的文献

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease.

Front Pharmacol. 2023 Aug 28;14:1218480. doi: 10.3389/fphar.2023.1218480. eCollection 2023.

pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case series.

Transl Cancer Res. 2022 Jul;11(7):2291-2298. doi: 10.21037/tcr-22-1216.

Exploration and Evaluation of Therapeutic Efficacy of Drug-Free Macromolecular Therapeutics in Collagen-Induced Rheumatoid Arthritis Mouse Model.

Macromol Biosci. 2020 May;20(5):e1900445. doi: 10.1002/mabi.201900445. Epub 2020 Mar 20.

Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.

J Control Release. 2017 Oct 10;263:139-150. doi: 10.1016/j.jconrel.2016.12.025. Epub 2016 Dec 24.

Design of smart HPMA copolymer-based nanomedicines.

J Control Release. 2016 Oct 28;240:9-23. doi: 10.1016/j.jconrel.2015.10.003. Epub 2015 Oct 3.

Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.

Biomater Sci. 2015 Jul;3(7):908-22. doi: 10.1039/C4BM00442F.

Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.

ACS Nano. 2014 Jan 28;8(1):719-30. doi: 10.1021/nn4053827. Epub 2013 Dec 10.

Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis.

Biomaterials. 2012 Oct;33(29):7174-81. doi: 10.1016/j.biomaterials.2012.06.024. Epub 2012 Jul 12.

Treatment of steroid-resistant pediatric nephrotic syndrome.

Korean J Pediatr. 2011 Aug;54(8):317-21. doi: 10.3345/kjp.2011.54.8.317. Epub 2011 Aug 31.

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2207-12. doi: 10.2215/CJN.03470410. Epub 2010 Aug 26.

本文引用的文献

Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease.

Pediatr Nephrol. 2010 Jun;25(6):1163-7. doi: 10.1007/s00467-010-1447-8. Epub 2010 Feb 6.

Severe respiratory adverse events associated with rituximab infusion.

Pediatr Nephrol. 2010 Jun;25(6):1193. doi: 10.1007/s00467-009-1408-2. Epub 2009 Dec 19.

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

Pediatr Pulmonol. 2009 Sep;44(9):922-34. doi: 10.1002/ppul.20864.

Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.

Transplantation. 2009 Jun 27;87(12):1837-41. doi: 10.1097/TP.0b013e3181a6bac5.

[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.

Leuk Lymphoma. 2009 Jun;50(6):904-11. doi: 10.1080/10428190902919200.

Fatal pulmonary fibrosis after rituximab administration.

Pediatr Nephrol. 2009 Sep;24(9):1753-5. doi: 10.1007/s00467-009-1195-9. Epub 2009 Apr 25.

Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.

Transplantation. 2008 Nov 15;86(9):1214-21. doi: 10.1097/TP.0b013e3181880b35.

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.

Leuk Lymphoma. 2008 Sep;49(9):1778-83. doi: 10.1080/10428190802270886.

Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.

Handb Exp Pharmacol. 2008(181):163-81. doi: 10.1007/978-3-540-73259-4_8.

Rituximab-induced interstitial lung disease.

Am J Hematol. 2007 Oct;82(10):916-9. doi: 10.1002/ajh.20910.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

New therapies, new concerns: rituximab-associated lung injury.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献